The most common side effects that occurred with RLAI were sleepiness, restlessness, tremors and muscle stiffness, stomach upset, constipation, dry mouth, feeling tired, and weight increase.
Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with risperidone, RLAI, and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.
Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with risperidone, RLAI, and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.
Risperidone and RLAI should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.
Risperidone, RLAI, and similar medications can raise the blood levels
of a hormone known as prolactin, causing a condition known as
hyperprolactinemia. Blood levels of prolactin remain elevated with
continued use. Some side effects seen with these medications include the
absence of a menstrual period; breasts producing milk; the development of
breasts by males; and the inability to achieve an erection. The co
|SOURCE Johnson & Johnson|
Copyright©2008 PR Newswire.
All rights reserved